| Literature DB >> 32590729 |
Di Ma1, Wenhui Gao, Junjiao Liu, Dan Kong, Yunfeng Zhang, Min Qian.
Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease common in premature infants and is one of the leading causes of disability and death in newborns. The Keap-1/Nrf2 signaling pathway plays an important role in antioxidant and anti-inflammatory.Ten clean-grade, healthy pregnant Sprague-Dawley rats (purchased from Experimental Animal Center of Peking university, China) naturally gave birth to 55 neonatal rats from which 40 were selected and randomly divided into a hyperoxia group and a control group (N = 20, each). Thirty-two BPD patient samples are from Neonatal Department of the second Hospital of Jilin University from November 30, 2016 to May 1 2019.In present study, we observed that lung tissues of the control group did not undergo obvious pathological changes, whereas in the hyperoxia group, lung tissues had disordered structures. With increased time of hyperoxia exposure, the alveolar wall became attenuated. Under hypoxia conditions, the activity of oxidative stress-related enzymes (CAT, GSH-Px, SOD) in lung samples was significantly lower than that before treatment. The expression level of Keap1 mRNA and protein in the hyperoxia group was slightly lower than that of control group. The expression of Nrf2 and HO-1 mRNA and protein in the hyperoxia group was significantly higher than that of control group. For the infants with BPD, we found that the activity of SOD, GSH-Px, and CAT was significantly different from those of control group.We constructed a premature BPD animal model and found the abnormal of oxidative stress in different groups and the expression levels of Keap1/Nrf2 signaling pathway-related molecules, and we validated the results in premature infants with BPD.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32590729 PMCID: PMC7328910 DOI: 10.1097/MD.0000000000020433
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Comparison the body weight and body length in different groups (P < .01).
Figure 2Morphological changes in lung tissues under the low-power microscope (H&E; 100×) and the high-power microscope (H&E; 400×).
Figure 3the activity of oxidative stress-related enzymes (CAT, GSH-Px, SOD) in lung samples was significantly lower than that before treatment (P < .05).
Figure 4Detection and comparison of mRNA expression levels of anti-oxidation related genes Keap1, Nrf2, and HO-1 in lung samples in different groups.
Figure 5Detection and comparison of protein levels of antioxidation-related genes Keap1, Nrf2, and HO-1 in lung samples in different groups.
Demographics and clinical characteristics of all patients.